In January of 2016, the St. Louis Shriners Hospital launched a new research partnership with Washington University School of Medicine. Our efforts focus on regenerative medicine – finding new ways through technology and therapies to help our patients grow new bone and cartilage.
Regenerative medicine, including tissue engineering, is considered by many to be the future of healing. It can range from using a patient’s own stem cells to “edit out” diseases to improving the material properties of bone and tissue growth.
Acclaimed scientist Farshid Guilak, Ph.D., is the research director. Dr. Guilak is also the co-director of the Washington University Center of Regenerative Medicine. His research has focused on the study of osteoarthritis, a painful and debilitating disease of the synovial joints. His lab has used a multidisciplinary approach to investigate the role of biomechanical factors in the onset and progression of osteoarthritis, as well as the development of new pharmacologic and stem-cell therapies for the disease.
Dr. Guilak has published more than 300 articles in peer-reviewed journals and has co-edited four books. He is also the president of the Orthopaedic Research Society and the Chair of the Skeletal Biologiy Structure and Regeneration NIH Study Section and the first Ph.D. member of the executive committee of the Orthopaedic Research and Education Foundation (OREF).
He works closely with world-renowned physician scientist Michael Whyte, M.D., who heads The Center for Metabolic Bone Disease and Molecular Research, which investigates and treats more than 100 rare bone diseases. One-third of the square footage of Shriners Hospitals for Children — St. Louis is dedicated to research.
Since the early 1920s, Shriners Hospitals for Children — St. Louis has had a close clinical and research partnership with Washington University School of Medicine. By collaborating with the school in this new “bench to bedside” research center, our relationship is even further strengthened, which will result in more effective and cutting-edge care for our patients.